Huntingtons Disease Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 77750 | Published Date: Oct 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL HUNTINGTONS DISEASE THERAPEUTICS INDUSTRY
    2.1 Summary about Huntingtons Disease Therapeutics Industry
    2.2 Huntingtons Disease Therapeutics Market Trends
        2.2.1 Huntingtons Disease Therapeutics Production & Consumption Trends
        2.2.2 Huntingtons Disease Therapeutics Demand Structure Trends
    2.3 Huntingtons Disease Therapeutics Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Antidopaminergics
        4.2.2 Anticonvulsants
        4.2.3 Antipsychotics
        4.2.4 Antidepressants
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Hosptial
        4.3.2 Clinic
        4.3.3 Research
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Antidopaminergics
        5.2.2 Anticonvulsants
        5.2.3 Antipsychotics
        5.2.4 Antidepressants
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Hosptial
        5.3.2 Clinic
        5.3.3 Research
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Antidopaminergics
        6.2.2 Anticonvulsants
        6.2.3 Antipsychotics
        6.2.4 Antidepressants
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Hosptial
        6.3.2 Clinic
        6.3.3 Research
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Antidopaminergics
        7.2.2 Anticonvulsants
        7.2.3 Antipsychotics
        7.2.4 Antidepressants
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Hosptial
        7.3.2 Clinic
        7.3.3 Research
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Antidopaminergics
        8.2.2 Anticonvulsants
        8.2.3 Antipsychotics
        8.2.4 Antidepressants
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Hosptial
        8.3.2 Clinic
        8.3.3 Research
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Antidopaminergics
        9.2.2 Anticonvulsants
        9.2.3 Antipsychotics
        9.2.4 Antidepressants
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Hosptial
        9.3.2 Clinic
        9.3.3 Research
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Auspex Pharmaceuticals
        10.1.2 Alnylam Pharmaceuticals
        10.1.3 Intellect Neurosciences Incorporation
        10.1.4 H. Lundbeck
        10.1.5 Prana Biotechnology Limited
        10.1.6 Raptor Pharmaceuticals
        10.1.7 Sangamo Biosciences
        10.1.8 Teva Pharmaceutical Industries
        10.1.9 Trophos SA
        10.1.10 Valeant Pharmaceuticals International
        10.1.11 Vertex Pharmaceuticals
        10.1.12 Roche
    10.2  Huntingtons Disease Therapeutics Sales Date of Major Players (2017-2020e)
        10.2.1 Auspex Pharmaceuticals
        10.2.2 Alnylam Pharmaceuticals
        10.2.3 Intellect Neurosciences Incorporation
        10.2.4 H. Lundbeck
        10.2.5 Prana Biotechnology Limited
        10.2.6 Raptor Pharmaceuticals
        10.2.7 Sangamo Biosciences
        10.2.8 Teva Pharmaceutical Industries
        10.2.9 Trophos SA
        10.2.10 Valeant Pharmaceuticals International
        10.2.11 Vertex Pharmaceuticals
        10.2.12 Roche
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
Table Huntingtons Disease Therapeutics Product Type Overview
Table Huntingtons Disease Therapeutics Product Type Market Share List
Table Huntingtons Disease Therapeutics Product Type of Major Players
Table Brief Introduction of Auspex Pharmaceuticals
Table Brief Introduction of Alnylam Pharmaceuticals
Table Brief Introduction of Intellect Neurosciences Incorporation
Table Brief Introduction of H. Lundbeck
Table Brief Introduction of Prana Biotechnology Limited
Table Brief Introduction of Raptor Pharmaceuticals
Table Brief Introduction of Sangamo Biosciences
Table Brief Introduction of Teva Pharmaceutical Industries
Table Brief Introduction of Trophos SA
Table Brief Introduction of Valeant Pharmaceuticals International
Table Brief Introduction of Vertex Pharmaceuticals
Table Brief Introduction of Roche
Table Products & Services of Auspex Pharmaceuticals
Table Products & Services of Alnylam Pharmaceuticals
Table Products & Services of Intellect Neurosciences Incorporation
Table Products & Services of H. Lundbeck
Table Products & Services of Prana Biotechnology Limited
Table Products & Services of Raptor Pharmaceuticals
Table Products & Services of Sangamo Biosciences
Table Products & Services of Teva Pharmaceutical Industries
Table Products & Services of Trophos SA
Table Products & Services of Valeant Pharmaceuticals International
Table Products & Services of Vertex Pharmaceuticals
Table Products & Services of Roche
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Huntingtons Disease Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
Table Global Huntingtons Disease Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Huntingtons Disease Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Huntingtons Disease Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Huntingtons Disease Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Huntingtons Disease Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Huntingtons Disease Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Huntingtons Disease Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Huntingtons Disease Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Huntingtons Disease Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Huntingtons Disease Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidopaminergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticonvulsants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antipsychotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidepressants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hosptial Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidopaminergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticonvulsants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antipsychotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidepressants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hosptial Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidopaminergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticonvulsants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antipsychotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidepressants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hosptial Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidopaminergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticonvulsants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antipsychotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidepressants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hosptial Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidopaminergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticonvulsants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antipsychotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidepressants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hosptial Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidopaminergics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Anticonvulsants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antipsychotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antidepressants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hosptial Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Clinic Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Research Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Auspex Pharmaceuticals 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Alnylam Pharmaceuticals 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Intellect Neurosciences Incorporation 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of H. Lundbeck 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Prana Biotechnology Limited 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Raptor Pharmaceuticals 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Sangamo Biosciences 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Teva Pharmaceutical Industries 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Trophos SA 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Valeant Pharmaceuticals International 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Vertex Pharmaceuticals 2017-2020e
Figure Huntingtons Disease Therapeutics Sales Revenue (Million USD) of Roche 2017-2020e
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Huntingtons Disease Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Huntingtons Disease Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Huntingtons Disease Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports